Interstitial lung diseases
Respiratory medicine meets other disciplines
Rheumatology: understanding connective tissue disease in patients with interstitial lung disease
Clinical
A joint ERS/European League Against Rheumatism (EULAR) session
Aims : To describe a diagnostic approach for patients presenting with respiratory symptoms and suspected connective tissue disease (CTD); to evaluate the evidence associated with indications for biopsy, including determining preferences for cryobiopsy versus video-assisted thoracoscopic surgery (VATS); and to determine the benefits and revise recommendation for therapy in CTD, including indications for monoclonal antibody (AB) therapy, particularly rituximab.
Target audience :
Adult pulmonologist/Clinician, Clinical researcher, Nurse, Physician in Pulmonary Training, Physiologist
16:50
Introduction
1
4073
16:55
Interstitial lung disease (ILD) and multicompartment assessment of CTD: where should the respiratory physician begin?
C. Denton(London, United Kingdom)
COI
2
4074
17:05
Does histology matter in ILD-CTD?
V. Poletti(Forlì, Italy)
COI
3
4075
17:15
Fibrotic CTD and interstitial pneumonia with autoimmune features (IPAF): immunosuppressive or/and anti-fibrotic treatment?
S. Danoff(Baltimore, United States)
COI
4
4076
17:25
B-cell suppressive therapy and monoclonal antibodies in CTD: does one size fit all?
D. Kyburz(Basel, Switzerland)
COI
5
4077
17:35
Discussion and Q&A
6
4078
. . .